Our Take
Early menopause is now confirmed as a consistent cardiovascular risk marker across regions and ethnicities, but the underlying mechanisms driving the South Asian gap remain unstudied.
Why it matters
Women in low and middle-income countries already face higher cardiovascular mortality; premature menopause compounds that risk and has been largely absent from clinical screening protocols. This epidemiological confirmation creates an opening to integrate menopause timing into risk stratification, starting now in South Asian populations.
Do this week
Cardiologists and primary-care clinicians: add 'age at menopause onset' as a standard cardiovascular risk question for all women patients over 40 this month, and flag those with early or premature menopause (before age 45) for intensive BP and lipid monitoring.
A 26-country study confirms premature menopause as a cardiovascular risk marker
Researchers from The University of Sydney, institutions across Europe, Asia, and Latin America analyzed data from 111,619 women across 26 countries as part of the Prospective Urban Rural Epidemiologic (PURE) study. The findings, published in The Lancet Obstetrics, Gynaecology, and Women's Health, establish a strong and consistent association between early menopause onset and major cardiovascular events.
Women in low and middle-income countries face a 53% increased risk of premature menopause (onset before age 40), with the median age of menopause at 47.5 years versus 50.6 years in high-income countries (per the published analysis). When compared specifically to European women, South Asian women showed a 34% increased risk, reaching menopause at a median age of 47.4 years against 50.7 years for their European counterparts.
The cardiovascular penalty is substantial. Women with premature menopause face a 27% increased risk of a major cardiovascular event such as heart attack or stroke; those with early menopause (ages 40-44) face a 14% increase (per the study). Critically, this association held consistent across all regions and ethnic groups examined, with no variation by income level or geography.
The gap exists but the cause remains a black box
The study's strength lies in its consistency: the same two survey questions were administered uniformly across 26 countries, eliminating most measurement noise. The South Asian elevation is real and replicated within a single large cohort, not inferred across separate studies.
But replication is not explanation. The authors note that women in low-income countries experience higher cardiovascular events despite lower prevalence of classical risk factors like hypertension, obesity, and diabetes. They identify secondary contributors: air pollution, poor diet, low education, and low grip strength. Early menopause is now positioned as an additional woman-specific risk factor, yet the paper does not isolate what drives the 34% excess in South Asian populations specifically.
This is the research gap that matters. Are South Asian women experiencing earlier reproductive aging due to metabolic factors, environmental toxins, nutritional deficiency, socioeconomic stress, genetic variation, or some combination? Without that answer, clinicians can observe the risk but cannot intervene upstream. The study flags a problem; it does not yet point to a solution.
Integrate menopause timing into risk screening, starting with South Asian women
The immediate actionable finding is that menopause age now qualifies as an independent, consistent cardiovascular risk marker. Standard risk assessment tools (Framingham, SCORE, etc.) do not currently incorporate it. That is a gap worth closing.
For clinicians: ask women over 40 whether they have reached menopause, and if so, at what age. Flag any onset before age 45 as a signal for intensified cardiovascular monitoring, regardless of traditional risk factor profiles. South Asian women deserve particular attention given the 34% excess incidence and the disproportionate burden of cardiovascular disease in low-income populations.
For researchers: the South Asian excess demands a mechanistic investigation. Population-level epidemiology has done its job; now the field needs granular biomarker studies, longitudinal reproductive tracking, and environmental exposure assessment to move from observation to prevention.